CA Patent

CA2145473A1 — Substituted heterocyclic carboxamidoesters their preparation and their use as pharmaceuticals

Assigned to Hoechst AG · Expires 1995-09-26 · 31y expired

What this patent protects

Substituted heterocyclic carboxamidoesters, their prep-aration and their use as pharmaceuticals The invention relates to substituted heterocyclic carboxamidoesters of the formula 1 (1) Said compounds are used as pharmaceuticals against fibrotic disorder…

USPTO Abstract

Substituted heterocyclic carboxamidoesters, their prep-aration and their use as pharmaceuticals The invention relates to substituted heterocyclic carboxamidoesters of the formula 1 (1) Said compounds are used as pharmaceuticals against fibrotic disorders and as inhibitors of proline hydroxylase and of collagen biosynthesis.

Drugs covered by this patent

Patent Metadata

Patent number
CA2145473A1
Jurisdiction
CA
Classification
Expires
1995-09-26
Drug substance claim
No
Drug product claim
No
Assignee
Hoechst AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.